Keywords Artificial intelligence Digital pathology Prostate cancer Radical prostatectomy Salvage therapy Prognostic model What does this study add? A novel digital pathology–based multimodal artificial intelligence (MMAI) biomarker was developed to predict long-term outcomes in men with biochemical recurrence (BCR) following radical prostatectomy (RP).
Alan W. Pollack
As seen in:
Nature,
rug.nl,
The Lancet,
HemOnc Today,
Journal of Clinical Oncology,
Augusta Free Press,
European Urology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Alan W.
Contact Alan W., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack